NDAINJECTIONINJECTABLEPriority Review
Approved
Mar 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug Shortage Active
HEPATOLITE is currently in shortage. Reason: Unavailable. This may impact manufacturing, supply chain, and quality hiring at the manufacturer.
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HEPATOLITE is a technetium Tc-99m labeled diagnostic imaging agent used for hepatobiliary scintigraphy to evaluate liver function and biliary tract patency. It is a radiopharmaceutical kit that requires radionuclide labeling before administration. The product helps clinicians assess hepatic uptake, excretion, and bile duct obstruction in patients with suspected biliary or hepatic disease.
LOE Approaching
Product faces declining market as imaging modalities shift; team likely consolidating or transitioning to next-generation diagnostic platforms.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job openings and a product in LOE-approaching stage, career prospects on HEPATOLITE are limited. Working on this product offers experience in managing mature, declining diagnostic franchises and navigating supply shortages—valuable for crisis management and sustainability roles.
Diagnostics Field SpecialistHospital Account Manager
Worked on HEPATOLITE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.